Zhu, Fan
He, Zhonghui
Zhu, Guiyin
Guan, Mengying
Yang, Shuang
Liu, Jiaming
Song, Qingqing
Zhao, Fangfang
Li, Li
Zhen, Guoxin
Peng, Tao
Hu, Yifei
Zhao, Ruilan
Ma, Yinghua
Funding for this research was provided by:
Capital’s Funds for Health Improvement and Research (2024-2G-7107)
Article History
Received: 5 August 2025
Accepted: 3 December 2025
First Online: 8 December 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved by the Ethics Committee of the Shunyi District Center for Disease Control and Prevention (Ethics Approval Number: 2024032802) and Peking University (IRB00001052-24182), and written informed consent was obtained from all participants and their parents before allocation. All procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki Declaration and its later amendments, or with comparable ethical standards. This trial was registered at the Chinese Clinical Trial Registry (ChiCTR-2500104984, 26/06/2025).